Dry Eye Rescue Is Offering Friends Of MDA A 20% Discount On All Products To Help With Your Eye Conditions
Click Here To Save Now
Jan 2, 2026
Author(s) by: Sheila Setork, OD Fact checked by: Kirsty Mackay Age-related macular degeneration (AMD) is one of the main causes of irreversible vision loss in older individuals, affecting approximately 20 million…
Dec 30, 2025
By: Michela Cimberle By: John Danias, MD, PhD By: Stefano Barabino, MD, PhD Fact checked by: Christine Klimanskis, ELS Oral microbiome In the complex, multifactorial pathophysiology of glaucoma, as in most…
Dec 30, 2025
By: Anthony DeFino Fact checked by: Eamon N. Dreisbach Key takeaways: Nufymco is indicated for the treatment of patients with a number of retinal diseases. The VEGF inhibitor is the…
Dec 22, 2025
Newly authorized treatment has fans, but skepticism persists amid sparse data by Randy Dotinga, Contributing Writer, MedPage Today December 19, 2025 • 4 min read Armed with a recent authorization from…
Dec 19, 2025
Researchers at the USC Roski Eye Institute, part of Keck Medicine of USC, are launching a phase 2b clinical trial examining if stem cells bioengineered to replace failing cells in the retina damaged by…
Dec 18, 2025
by: Julie Poteet, Cecelia Koetting & Priya S. Vakharia Abstract No current treatments are curative for age-related macular degeneration (AMD), and preventing disease progression is challenging. Dietary factors play a role in…
Dec 18, 2025
Dear friends, We want to let you know that the Macular Degeneration Association will be taking a short holiday break! We’ll be closed from December 24, 2025, to January 1,…
Dec 15, 2025
Regeneron has partnered with The Foundation Fighting Blindness to raise awareness about an ongoing clinical trial investigating subcutaneously administered investigational medicines as potential treatments for geographic atrophy (GA). The study…
Dec 9, 2025
Author(s): Martin David Harp Key Takeaways Xelafaslatide, a Fas inhibitor, shows promise in protecting retinal cells and slowing GA progression in dry AMD. The phase 1b study evaluated safety and…
Dec 9, 2025
Author(s):Vittorio Mena, OD, MS, Fact checked by: Matt Hoffman, Kirsty Mackay Our patients benefit from a preventive approach that includes lifestyle adjustment, nutrition, and supplementation. Eyes are an integral part of overall…
Dec 9, 2025
Author(s): Jordana Joy, Associate Editor Fact checked by: Ron Panarotti The survey was conducted by OnePoll on October 2025 and included 1000 US patients with dry eye. Key takeaways Dry eye…
Dec 3, 2025
Thank you to all who participated in yesterday’s # GivingTuesday. Your support fuels vital research and inspires hope for a brighter future.
Dec 1, 2025
by: Jack Dunn Judi Dench recently shared that she “can’t recognize anybody” due to her eye condition. When asked by ITV why she’s stepped away from acting, Dench told the outlet, “I can’t…
Dec 1, 2025
Join us for #GivingTuesday2025 on Tuesday, December 2nd, from 12:00 AM to 11:59 PM! Your generous support can make a transformative impact in our fight against macular degeneration. Together, we…
Nov 26, 2025
Happy Thanksgiving! The Macular Degeneration Association would like to express our gratitude for your support and thoughtfulness. “As we show our appreciation, we must remember that the highest form of…
Nov 26, 2025
Dr. Long, thank you for explaining the difference between low vision and legal blindness. Low vision vs. legally blind—what’s the difference? The terms “low vision” and “legally blind” are often…
Nov 25, 2025
The research team is now monitoring 12 more participants who received higher doses of 150,000 and 250,000 cells. If no safety issues are identified, the investigators plan to move on…
Nov 25, 2025
By: Anthony DeFino Fact checked by: Nancy Hemphill, ELS, FAAO Key takeaways: The decision is supported by positive visual acuity gains found in the phase 3 QUASAR trial. This is…
Nov 24, 2025
By Justin Cooper Fact checked by; Christine Klimanskis, ELS Key takeaways: Patients with diabetes taking GLP-1s had a twofold higher risk for wet AMD development in unadjusted and adjusted models.…
Nov 24, 2025
You’ve heard of Vitamin A for your eyes… but did you know there’s a family of natural pigments that may be even more essential for protecting your vision? 👁️ In…
Nov 21, 2025
By Anna Giorgi Published on November 18, 2025 Medically reviewed by Karina Tolentino, RD Ginger is one of several foods that may have strong anti-inflammatory effects. Ginger isn’t the only anti-inflammatory food,…
Nov 18, 2025
As winter sets in, many of us may experience symptoms that differ from those in other times of the year. One common issue that tends to worsen in winter…
Nov 18, 2025
Author(s): Kassi Filkins Fact checked by: Kirsty Mackay Key Takeaways SYFOVRE (pegcetacoplan injection) delays GA lesion growth by approximately 1.5 years compared to sham treatment in AMD patients. The GALE study,…
Nov 17, 2025
In this episode of The Eye-Q Podcast, Dr. Rani Banik sits down with Dr. Debbie Ozment—an integrative dentist with over 40 years of experience—to explore the mouth-body connection. They discuss…
Nov 11, 2025
Happy Veterans Day. Thank you to all who serve and their families for their sacrifices. “As we express our gratitude, we must never forget that the highest appreciation is not…
Nov 7, 2025
By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: eSight Go uses two OLED screens to boost visual acuity for people with central vision loss. The device is…
Nov 6, 2025
By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Patients with diabetes taking GLP-1s had a twofold higher risk for wet AMD development in unadjusted and adjusted models.…
Nov 5, 2025
By: Justin Cooper Fact checked by: Christine Klimanskis, ELS Key takeaways: Consumers are more familiar with smart eye wear than they were 2 years ago. Social media is the main…
Nov 4, 2025
Author(s) : Martin David Harp Key Takeaways AXPAXLI is a bioresorbable hydrogel incorporating axitinib, targeting wet AMD and other retinal diseases with anti-angiogenic properties. The SOL-R trial compares AXPAXLI’s six-month dosing…
Oct 30, 2025
Author(s): Sydney M Crago Key Takeaways Iron dysregulation contributes to oxidative stress, inflammation, and ferroptosis, driving retinal degeneration in dry AMD and GA. Transferrin, regulating iron homeostasis, is a potential…